BCAT
Overvalued by 102.5% based on the discounted cash flow analysis.
Market cap | $1.77 Billion |
---|---|
Enterprise Value | $1.76 Billion |
Dividend Yield | $1.53 (13.1584447144593%) |
Earnings per Share | $1.78 |
Beta | 0.72 |
Outstanding Shares | - |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 9.23 |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | - |
Enterprise Value to Net Income | - |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
BlackRock Capital Allocation Trust’s (BCAT) investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust invests in a portfolio of equi...